Is apolipoprotien E codon 112 polymorphisms associated with recurrent pregnancy loss?

American Journal of Reproductive Immunology

Volumn 64, Issue 2, 2010, Pages 87-92

  Ozornek, Hakan ^a   Ergin, Elif ^a   Jeyendran, Rajasingam S ^b,c   Ozay, Alev T ^a   Pillai, Delanie ^b   Coulam, Carolyn ^c,d  

^a Eurofertil Reproductive Health Center   (Turkey)

^b Andrology Laboratory Services Inc   (United States)

^c Millenova Immunology Laboratories   (United States)

^d Rinehart Center for Reproductive Medicine   (United States)

Author keywords

Apo E4 codon 112C and 158C; Apolipoprotein E4; Recurrent pregnancy loss

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; CYTOSINE; DNA; CODON; ISOPROTEIN;

ADULT; ARTICLE; CODON; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DNA EXTRACTION; FEMALE; FEMALE FERTILITY; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT ABORTION; RISK ASSESSMENT; SMEAR; WOMEN'S HEALTH; ABORTION, HABITUAL; COMPLICATION; GENETIC ASSOCIATION; GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; VEIN THROMBOSIS;

ABORTION, HABITUAL; ADULT; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CODON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; VENOUS THROMBOSIS;

EID: 77958109977     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2010.00814.x     Document Type: Article

References (37)

1. Mahley RW: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240:622-630.
2. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC: Apoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 2002; 155:487-495.
3. Rall SC, Weisgraber KH, Mahley RW: Human apolipoprotein E: the complete amino acid sequence. J Biol Chem 1982; 257:4171-4178.
4. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST: APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. Nat Genet 1995; 10:486-488.
5. Goodman C, Goodman CS, Hur J, Jeyendran RS, Coulam CB: The association of apoprotien E polymorphisms with recurrent pregnancy loss. Am J Reprod Immunol 2009; 61:34-38.
6. Coulam CB, Jeyendran RS, Fishel LA, Roussev RG: Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol 2006; 55:360-368.
7. De Valois JC, van Schaik CC, Verzijlbergen F, van Ramshorst B, Eikelboom BC, Meuwissen OJA: Contrast venography: from gold standard to "golden backup" inclinically suspected deep vein thrombosis. Eur J Radiol 1990; 11:131-137.
8. Aggerbeck LP, Wetterau JR, Weisgraber KH, Wu C-SC, Lindgren FT: Human apolipoprotein E3 in aqueous solution. II. Properties of the amino-and carboxylterminal domains. J Biol Chem 1988; 263:6249.
9. Dong L-M, Weisgraber KH: Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem 1996; 271:19053-19057.
10. Weisgraber KH: Apolipoprotein E: structure-function relationships. Adv Protein Chem 1994; 45:249-302.
11. Weisgraber KH: Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J Lipid Res 1990; 31:1503-1511.
12. Polacek D, Beckmann MW, Schreiber JR: Rat ovarian apolipoprotein E: localization and gonadotropic control of messenger RNA. Biol Reprod 1992; 46:65-72.
13. Finch CE, Sapolsky RM: The evolution of Alzheimer disease the reproductive schedule and apoE isoforms. Neurobiol Aging 1999; 20:407-428.
14. Gerdes LU, Gerdes C, Hansen PS, Klausen IC, Faergeman O: Are men carrying the apolipoprotein epsilon 4-or epsilon 2 allele less fertile than epsilon 3 epsilon 3 genotypes? Hum Genet 1996; 98:239-242.
15. Corbo RM, Scacchi R, Cresta M: Differential reproductive efficiency associated with common apolipoprotein E alleles in postreproductive aged subjects. Fertil Steril 2004; 81:104-107.
16. Mahley RW, Rall SC: Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000; 1:507-537.
17. Corbo RM, Scacchi R: Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele?. Ann Hum Genet 1999; 63:301-310.
18. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147:3815-3822.
19. Curtiss LK, Boisvert WA: Apolipoprotein E and atherosclerosis. Curr Opin Lipidol 2000; 11:243-251.
20. Tziakas DN, Chalikias GK, Antonoglou CO, Veletza S, Tentes IK, Kortsaris AX, Hatseras DI, Kaski JC: Apolipoprotein E Genotype and Circulating Interleukin-10 Levels in Patients With Stable and Unstable Coronary Artery Disease. J Am Coll Cardiol 2006; 48:2471-2481.
21. Miyata M, Smith JD: Apolipoprotein E allele-specific anti-oxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 1996; 14:55-61.
22. Chaouat G, Menu E, de Smedt D, Khrihnan L, Hui L, Assal Meliani A, Martal J, Raghupathy R, Wegmann TG: The emerging role of IL-10 in pregnancy. Am J Reprod Immunol 1996; 35:325-329.
23. Wang P, Wu P, Siegel MI, Egan RW, Billah MM: Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995; 270:9558-9563.
24. Murphy SP, Sharma S: IL-10 and Pregnancy. In Immunology of Pregnancy, G Mor (ed). New York, Springer, 2006, pp 26-36.
25. Danesh J, Wheeler JG, Hirschfield GM, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GDO, Pepys MB, Gudnason V: C-reactive protein andother circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350:1387-1397.
26. Strittmatter WJ, Roses AD: Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci USA 1995; 92:4725-4727.
27. Hanlon CS, Rubinsztein DC: Arginine residues at codon 112 and 158 in the apolipoprotien E gene correspond to the ancestral state in humans. Atherosclerosis 1995; 112:85-90.
28. Fullerton SM, Clark AG, Weiss KM, Nickerson DA, Taylor SL, Stengard JH, Salomaa V, Vartianen E, Perola M, Boerwinkle E, Sing CF: Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet 2000; 67:881-900.
29. Utermamm G, Steinmetz A, Weber W: Genetic control of human apolipoprotein. Hum Genet 1982; 60:344-351.
30. Menzel HJ, Kladetzky RG, Assmann G: Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis 1983; 3:310.
31. Mahley RW, Weisgraber KH, Huang Y: Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzeimer's disease. Proc Natl Acad Sci USA 2006; 103:5644-5651.
32. Hashimoto Y, Jiang H, Niikura T, Ito Y, Hagiwara A, Umezawa K, Abe Y, Murayama Y, Nishimoto I: Neuronal apoptosis by apolipoprotein E4 through low-density lipoprotein receptor-related protein and heterotrimeric GTPases. J Neurosci 2000; 20:8401-8409.
33. Pedersen WA, Chan SL, Mattson MP: A mechanism for the neuroprotective effect of apolipoprotein E: isoform-specific modification by the lipid peroxidation prodouct 4-hydroxymonenal. J Neurochem 2000; 74:1426-1433.
34. Seiler A, Schneider M, Föster H, Roth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Rådmark O, Wurst W, Bornkamm GW, Schweizer U, Conrad M: Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent-and AIF-mediated cell death. Cell Metab 2008; 8:237-248.
35. Cannon CP, Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM: Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes. N Engl J Med 2004; 350:1495-1504.
36. Goodman C, Coulam CB, Jeyendran RS, Fishel LA, Roussev RG: Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Reprod Immunol 2006; 56:230-236.
37. Goodman C, Coulam CB, Jeyendran RS, Fishel LA, Roussev RG: Multiple thrombophilic gene mutations are risk factors for implantation failure. Reprod Biomed Online 2006; 12:322-327.